Literature DB >> 10918415

Pre-emptive ribavirin for 'RSV' in BMT.

J DeVincenzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10918415     DOI： 10.1038/sj.bmt.1702436

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.

Authors:  Rodrigo Martino; Rocío Parody Porras; Nuria Rabella; John V Williams; Elena Rámila; Nuria Margall; Rosa Labeaga; James E Crowe; Pedro Coll; Jorge Sierra
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

2.  Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model.

Authors:  Hayat Caidi; Congrong Miao; Natalie J Thornburg; Ralph A Tripp; Larry J Anderson; Lia M Haynes
Journal:  Antiviral Res       Date:  2018-04-17       Impact factor: 5.970

Review 3.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

4.  Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.

Authors:  Angela J Peck; Janet A Englund; Jane Kuypers; Katherine A Guthrie; Lawrence Corey; Rhoda Morrow; Robert C Hackman; Anne Cent; Michael Boeckh
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.